Blog
RSS FeedPosted by Michael Wonder on 25 Feb 2021
AbbVie’s Skyrizi for the treatment of moderate to severe plaque psoriasis now publicly reimbursed across Canada
24 February 2021 - Prince Edward Island lists Skyrizi on its Pharmacare Formulary effective 22 February 2021. ...
Posted by Michael Wonder on 25 Feb 2021
Multiple sclerosis treatments
25 February 2021 - From 1 March 2021, more people will be able to access multiple sclerosis treatments for longer. ...
Posted by Michael Wonder on 21 Feb 2021
Ontario makes commitment to funding CF drugs after approval process completed
19 February 2021 - Ontario’s Health Minister Christine Elliott says life-saving cystic fibrosis medications that are inching their way through ...
Posted by Michael Wonder on 18 Feb 2021
Fresenius Kabi Canada launches Idacio (adalimumab injection) a biosimilar to Humira (adalimumab) for the treatment of multiple chronic inflammatory conditions
18 February 2021 - Biosimilars offer patients access to affordable, meaningful medicines ...
Posted by Michael Wonder on 18 Feb 2021
HLS Therapeutics provides update on private and public payer reimbursement for Vascepa
16 February 2021 - Active negotiations have also begun with the pan-Canadian Pharmaceutical Alliance for reimbursement of Vascepa by publicly funded ...
Posted by Michael Wonder on 15 Feb 2021
The price of a life: stark choice facing Kiwis needing unfunded medicines
16 February 2021 - Sick New Zealanders who need unfunded medicines are faced with a stark choice: turn to crowdfunding ...
Posted by Michael Wonder on 12 Feb 2021
PHARMAC widens access to funded treatments for multiple sclerosis
12 February 2021 - PHARMAC announced today that it will be widening access to all funded multiple sclerosis treatments from 1 ...
Posted by Michael Wonder on 11 Feb 2021
FDA’s generic drug program in 2020 helped ensure availability of high quality, affordable drugs amid COVID-19
11 February 2021 - Generic drugs play a vital role in facilitating access to lifesaving medicines for Americans and remain a ...
Posted by Michael Wonder on 11 Feb 2021
Cystic fibrosis advocate asks P.E.I. to fast-track coverage of new 'mind-blowing' drug
10 February 2021 - ‘It’s the closest thing we’ve ever had to a cure’. ...
Posted by Michael Wonder on 10 Feb 2021
New drugs entering Canada at steady rate over past 5 years - Canada still among top 10 OECD countries in terms of access to new drugs
10 February 2021 - The latest edition of the Patented Medicine Prices Review Board Meds Entry Watch reports that 40 new-to-Canada ...
Posted by Michael Wonder on 09 Feb 2021
Teen thriving on PHARMAC funded medicine
9 February 2021 - 14 year old Bruno Cettina is living his best life thanks to a medicine funded by PHARMAC. ...
Posted by Michael Wonder on 07 Feb 2021
Timaru mother with terminal bowel cancer calling on Government to fund cetuximab
5 February 2020 - A terminally ill woman shelling out more than $12,000 a year for extra time with her ...
Posted by Michael Wonder on 03 Feb 2021
Cystic fibrosis survivor calls for life-saving drug Trikafta to be funded as PHARMAC dangles hope
3 February 2021 - Drug buying agency PHARMAC has revealed it is willing to go directly to the Government for ...
Posted by Michael Wonder on 03 Feb 2021
Patients gain early access to Pfizer's atopic dermatitis drug
3 February 2021 - People living in the UK with severe atopic dermatitis are to be given early access to ...
Posted by Michael Wonder on 02 Feb 2021
Cystic fibrosis sufferer Bella Powell hits out at drug company for stalling PHARMAC funding
2 February 2021 - A cystic fibrosis patient is calling out American drug company Vertex, for not achieving PHARMAC funding. ...